Recombinant Anti-MET × Anti-VEGF IgG-IgG (MV10A) (CAT#: BSIG-MZ001)
This bispecific antibody shows significant synergistic suppression effects against HGF- and VEGF-dependent HUVEC cell proliferation. It is also capable of inhibiting the phosphorylation of AKT and suppressing tumor cell invasion as well.
Specific Inquiry
Specifications
- Target
- MET & VEGF
- Type
- IgG-IgG
- Species Reactivity
- Human
- Target 1
- MET
- Host Species 1
- Human
- Target 2
- VEGF
- Host Species 2
- Human
- Application
- ELISA
- Related Disease
- Gastric cancer
Target
- Target 1
- MET
- Gene ID
- 4233
- UniProt ID
- A0A024R759
- Alternative Names
- MET; MET proto-oncogene, receptor tyrosine kinase; HGFR; AUTS9; RCCP2; c-Met; hepatocyte growth factor receptor; SF receptor; HGF receptor; HGF/SF receptor; proto-oncogene c-Met; scatter factor receptor; tyrosine-protein kinase Met; met proto-oncogene tyrosine kinase
- Target 2
- VEGF
- Alternative Names
- VEGF; Vascular endothelial growth factor
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
Customer Reviews and Q&As
There are currently no Customer reviews or questions for BSIG-MZ001. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.